Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix

Arif Hameed, David S. Miller, Carolyn Y. Muller, Robert L. Coleman, Jorge Albores-Saavedra

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Human chorionic gonadotropin (β-hCG) has been detected within tissue homogenates, culture fluid, and sera of patients with squamous cell carcinoma of the cervix. Studies regarding in vivo localization of β-hCG in squamous cell carcinoma of the cervix are scant and conflicting. Cervical samplings (biopsy and/or curettage specimens) of 63 cases of poorly differentiated invasive squamous cell carcinoma of the cervix were initially stained by the immunoperoxidase technique for the presence of β-hCG and human placental lactogen (hPL). Based on β-hCG reactivity, patients were divided into β- hCG-positive and β-hCG-negative groups. Thirty-three of the 63 (52%) cases showed localization of β-hCG in tumor cells. Subsequent specimens of patients, who underwent surgical treatment, were likewise examined for β-hCG reactivity. These surgical specimens showed focal β-hCG reactivity in the β-hCG-positive group only. The β-hCG reactivity was seen in both high-grade SIL (CIN III), invasive squamous cell carcinoma, and its metastases. The focal β-hCG reactivity was predominantly confined to the peripheral tumor cells at the stromal-epithelial interface in noninvasive and invasive lesions. Intensity of immunostaining was moderate to strong. The β-hCG staining was observed in different cancer stages and in various age groups. No hPL reactivity was seen in any cases. Poorly differentiated squamous cell carcinoma of uterine cervix showing immunoreactivity for β-hCG should be distinguished from choriocarcinoma and other trophoblastic tumors.

Original languageEnglish (US)
Pages (from-to)381-386
Number of pages6
JournalInternational Journal of Gynecological Pathology
Volume18
Issue number4
StatePublished - Oct 1999

Fingerprint

Chorionic Gonadotropin
Cervix Uteri
Squamous Cell Carcinoma
Placental Lactogen
Trophoblastic Neoplasms
Neoplasms
Choriocarcinoma
Curettage
Stromal Cells
Immunoenzyme Techniques
Age Groups
Staining and Labeling
Neoplasm Metastasis
Biopsy
Serum

Keywords

  • β-hCG
  • Squamous cell carcinoma
  • Uterine cervix

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix. / Hameed, Arif; Miller, David S.; Muller, Carolyn Y.; Coleman, Robert L.; Albores-Saavedra, Jorge.

In: International Journal of Gynecological Pathology, Vol. 18, No. 4, 10.1999, p. 381-386.

Research output: Contribution to journalArticle

Hameed, Arif ; Miller, David S. ; Muller, Carolyn Y. ; Coleman, Robert L. ; Albores-Saavedra, Jorge. / Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix. In: International Journal of Gynecological Pathology. 1999 ; Vol. 18, No. 4. pp. 381-386.
@article{9718b740794a44a58a540d6880d9d326,
title = "Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix",
abstract = "Human chorionic gonadotropin (β-hCG) has been detected within tissue homogenates, culture fluid, and sera of patients with squamous cell carcinoma of the cervix. Studies regarding in vivo localization of β-hCG in squamous cell carcinoma of the cervix are scant and conflicting. Cervical samplings (biopsy and/or curettage specimens) of 63 cases of poorly differentiated invasive squamous cell carcinoma of the cervix were initially stained by the immunoperoxidase technique for the presence of β-hCG and human placental lactogen (hPL). Based on β-hCG reactivity, patients were divided into β- hCG-positive and β-hCG-negative groups. Thirty-three of the 63 (52{\%}) cases showed localization of β-hCG in tumor cells. Subsequent specimens of patients, who underwent surgical treatment, were likewise examined for β-hCG reactivity. These surgical specimens showed focal β-hCG reactivity in the β-hCG-positive group only. The β-hCG reactivity was seen in both high-grade SIL (CIN III), invasive squamous cell carcinoma, and its metastases. The focal β-hCG reactivity was predominantly confined to the peripheral tumor cells at the stromal-epithelial interface in noninvasive and invasive lesions. Intensity of immunostaining was moderate to strong. The β-hCG staining was observed in different cancer stages and in various age groups. No hPL reactivity was seen in any cases. Poorly differentiated squamous cell carcinoma of uterine cervix showing immunoreactivity for β-hCG should be distinguished from choriocarcinoma and other trophoblastic tumors.",
keywords = "β-hCG, Squamous cell carcinoma, Uterine cervix",
author = "Arif Hameed and Miller, {David S.} and Muller, {Carolyn Y.} and Coleman, {Robert L.} and Jorge Albores-Saavedra",
year = "1999",
month = "10",
language = "English (US)",
volume = "18",
pages = "381--386",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix

AU - Hameed, Arif

AU - Miller, David S.

AU - Muller, Carolyn Y.

AU - Coleman, Robert L.

AU - Albores-Saavedra, Jorge

PY - 1999/10

Y1 - 1999/10

N2 - Human chorionic gonadotropin (β-hCG) has been detected within tissue homogenates, culture fluid, and sera of patients with squamous cell carcinoma of the cervix. Studies regarding in vivo localization of β-hCG in squamous cell carcinoma of the cervix are scant and conflicting. Cervical samplings (biopsy and/or curettage specimens) of 63 cases of poorly differentiated invasive squamous cell carcinoma of the cervix were initially stained by the immunoperoxidase technique for the presence of β-hCG and human placental lactogen (hPL). Based on β-hCG reactivity, patients were divided into β- hCG-positive and β-hCG-negative groups. Thirty-three of the 63 (52%) cases showed localization of β-hCG in tumor cells. Subsequent specimens of patients, who underwent surgical treatment, were likewise examined for β-hCG reactivity. These surgical specimens showed focal β-hCG reactivity in the β-hCG-positive group only. The β-hCG reactivity was seen in both high-grade SIL (CIN III), invasive squamous cell carcinoma, and its metastases. The focal β-hCG reactivity was predominantly confined to the peripheral tumor cells at the stromal-epithelial interface in noninvasive and invasive lesions. Intensity of immunostaining was moderate to strong. The β-hCG staining was observed in different cancer stages and in various age groups. No hPL reactivity was seen in any cases. Poorly differentiated squamous cell carcinoma of uterine cervix showing immunoreactivity for β-hCG should be distinguished from choriocarcinoma and other trophoblastic tumors.

AB - Human chorionic gonadotropin (β-hCG) has been detected within tissue homogenates, culture fluid, and sera of patients with squamous cell carcinoma of the cervix. Studies regarding in vivo localization of β-hCG in squamous cell carcinoma of the cervix are scant and conflicting. Cervical samplings (biopsy and/or curettage specimens) of 63 cases of poorly differentiated invasive squamous cell carcinoma of the cervix were initially stained by the immunoperoxidase technique for the presence of β-hCG and human placental lactogen (hPL). Based on β-hCG reactivity, patients were divided into β- hCG-positive and β-hCG-negative groups. Thirty-three of the 63 (52%) cases showed localization of β-hCG in tumor cells. Subsequent specimens of patients, who underwent surgical treatment, were likewise examined for β-hCG reactivity. These surgical specimens showed focal β-hCG reactivity in the β-hCG-positive group only. The β-hCG reactivity was seen in both high-grade SIL (CIN III), invasive squamous cell carcinoma, and its metastases. The focal β-hCG reactivity was predominantly confined to the peripheral tumor cells at the stromal-epithelial interface in noninvasive and invasive lesions. Intensity of immunostaining was moderate to strong. The β-hCG staining was observed in different cancer stages and in various age groups. No hPL reactivity was seen in any cases. Poorly differentiated squamous cell carcinoma of uterine cervix showing immunoreactivity for β-hCG should be distinguished from choriocarcinoma and other trophoblastic tumors.

KW - β-hCG

KW - Squamous cell carcinoma

KW - Uterine cervix

UR - http://www.scopus.com/inward/record.url?scp=0032833346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032833346&partnerID=8YFLogxK

M3 - Article

C2 - 10542948

AN - SCOPUS:0032833346

VL - 18

SP - 381

EP - 386

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 4

ER -